proteinase specificity (P 2 , P 1 and P' 2 ) with the genetically coded amino acids UK (minus cysteine) plus norleucine generated 8000 permutations. Screening this library with biotinylated a-chymotrypsin under appropriate conditions revealed a small number (<0.05%) of beads that selectively bound the labeled proteinase. The sequences present on these active beads were determined, and found to have a well-defined consensus. Analysis of chymotrypsin inhibition in solution using re-synthesized peptides reveals that the sequences identified are potent inhibitors with K i values in the nanomolar range. These results show that directed randomization of the canonical loop is a powerful way of generating proteinase inhibitors with targeted specificities. Incorporation of selective random changes within a defined structural framework is found to be an effective means of generating variation in large synthetic systems. The functional basis for inhibition by the identified sequences is discussed.
Introduction
Almost all biochemical processes rely upon specific molecular recognition between peptides or proteins and other biologically active molecules. Combinatorial approaches have recently provided new strategies capable of selecting bioactive molecules from large libraries of compounds (for reviews, see Gallop et al., 1994; Gordon et al., 1994) . Such methods reduce the need for repetitive syntheses of related compounds, and closely link the synthetic and screening processes.
Proteinases play important roles in the regulation of many biological processes, by post-translational modification of precursor proteins or by controlling protein turnover (Neurath, 1989) . Regulation of proteolytic activity in such systems is vital, and many pathways that deploy proteinase enzymes use specific inhibitor proteins to control the balance between desired and undesired proteolysis. Like their target proteinases, inhibitors are ubiquitous, and can be found throughout the animal and plant Present address: G. J. Domingo, Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge, UK.
Abbreviations used: BBI, Bowman-Birk inhibitor; PBS-T, phosphate buffered saline containing 0.05% (v/v) pH 7.4 ; Pn, the nth peptide subsite of a substrate or inhibitor on the carboxyl side of the scissile bond; P' n, the nth peptide subsite of a substrate or inhibitor on the amino side of the scissile bond; STI, soybean trypsin inhibitor.
kingdoms. The pivotal role of proteinases in biological regulation makes them important targets for therapeutic intervention, and there is much interest in identification of new inhibitors. A key question in inhibitor design is how to construct novel inhibitors with directed specificities. Combinatorial libraries of potential inhibitor compounds offer an attractive way to achieve this.
Inhibition by proteinase inhibitor proteins involves the formation of a stoichiometric enzymeinhibitor complex, which resembles a Michaelis complex. Unlike a good substrate, however, the energy barrier for hydrolysis is large and unfavorable, resulting in low rates of hydrolysis (Laskowski & Kato, 1980; Read & James, 1986; Longstaff et al., 1990) . In most cases the inhibition is mediated by an exposed loop that is fixed in a characteristic ''canonical'' conformation, and which fits into the active site of the proteinase in a manner thought to be similar to that of a substrate (Laskowski & Kato, 1980; Bode & Huber, 1992) . This loop is frequently constrained by the presence of disulfide bridges and/or extensive hydrogen-bonding networks that act to lock the structure into the correct canonical structure. The sequence of this loop determines the specificity of the inhibition, which mirrors the specificity of proteinases for their substrates. For example, most trypsin inhibitors have Arg or Lys as their P 1 residue.
Inhibitors of the Bowman-Birk family have a network of conserved disulfide bridges that help form a symmetrical structure of two tricyclic domains (Chen et al., 1992; Werner & Wemmer, 1992; Lin et al., 1993) , each containing an independent serine proteinase binding site (Figure 1A) . The binding loop is contained within a nonapeptide region joined via a disulfide between flanking cysteine residues ( Figure 1B ). The identity of the amino acid residue at the P 1 site on each domain is the main determinant of the serine proteinase inhibited. Native domains possess lysine or arginine for trypsin, leucine or tyrosine for chymotrypsin, and alanine for elastase (Ikenaka & Norioka, 1986) . In addition, serine is highly conserved at the P' 1 position and proline at the P' 3 position.
The individual loop regions of Bowman-Birk inhibitor (BBI) are well suited as a models for proteinase inhibitor design. Nishino et al. (1977) first demonstrated that a nine residue monocyclic peptide based on the trypsin binding domain was sufficient to retain the inhibitory properties of the native inhibitor. More recently, Maeder et al. (1992) designed an 11 residue monocyclic peptide based on the core nine residue sequence of the anti-tryptic loop region of the Bowman-Birk inhibitor, D4 from Macrotyloma axillare. This peptide exhibits an improved K i value against trypsin, and better resistance to proteolysis (unpublished results). We have used this peptide sequence to produce a defined mixture of P 1 Figure 1 . Structure of the Bowman-Birk inhibitor. The coordinates of Bowman-Birk inhibitor protein (Werner & Wemmer, 1992) were obtained from the Brookhaven Protein Data Bank and displayed using the program Quanta. A, The backbone of the BowmanBirk inhibitor is shown as a ribbon. The two proteinase-binding loops are colored red, and the side-chains of the cystine residues are in yellow. B, Detail of the three-dimensional structure of the binding loop. The residues that were randomized are indicated by arrows.
variants in order to study proteinase-inhibitor recognition (Domingo et al., 1995) . We now report the creation of an immobilized cyclic combinatorial peptide library using this 11 residue sequence as a template to screen for inhibitors active against a-chymotrypsin. Multiplicity has been generated by incorporating the natural amino acids (minus cysteine but plus norleucine) in the P 2 , P 1 and P' 2 positions using the ''one bead, one peptide'' approach, obtained from split synthesis (Furka et al., 1991; Lam et al., 1991) , to generate 8000 variants. To date, most combinatorial synthetic libraries have been created using complete randomization. Our approach contrasts with this, in that we have elected to conserve a framework of residues in order to maintain a structure-inducing scaffold from our archetypal inhibitor. This will result in a library that, while less diverse than those with totally random sequences, is better targeted at the generation of active proteinase inhibitors. Sequence of the inhibitor library. The resin-bound inhibitor library was synthesized with a pentaglycine spacer between the TentaGel support and an 11 residue inhibitor sequence containing three sites that were subject to randomization. The random sites, marked Xaa, had all the genetically encoded amino acids minus cysteine, plus norleucine to give 20 possible combinations. This results in a library with 8000 permutations.
Screening of the inhibitor library
Screening of the library was performed indirectly by using biotinylated a-chymotrypsin, which was detected by means of an avidin-alkaline phosphatase conjugate to provide an enzyme-linked assay. For this reason, it was first important to establish that biotinylation of chymotrypsin did not perturb the enzyme activity. To ensure that only active species were present, the biotin-chymotrypsin was purified by affinity chromatography on STISepharose. The kinetic parameters of the modified enzyme (biotin to protein 0.9:1; K m 53 mM, k cat 42 s −1 ) were found not to differ significantly from the unmodified species (K m 48 mM, k cat 49 s −1 ). The library was screened using a relatively low concentration of biotinylated chymotrypsin in order to select only the most tightly binding species. This procedure was found to result in the selection of a small number of beads (approximately 13 very highly stained beads out of a total of 032,000). A typical ''positive'' bead is shown in Figure 3 , illustrating the great distinction between the positive beads and the remainder. The positive beads were individually isolated, and their sequences determined by Edman degradation.
Sequences discovered
In all cases only a single sequence was obtained from each bead, and repetitive yields from the Edman reactions were 85 to 90% at each position. Of the 13 sequences that were found, ten were confirmed as potent competitive inhibitors of chymotrypsin after subsequent re-synthesis; these sequences are given in Table 1 . In addition, we found three sequences that did not display inhibition activity after re-synthesis. These sequences were SCEWSIPPQCG 5 , SCTTSTPPQCG 5 and SCQQSYPPQCG 5 . Multiple copies were found for most of the active peptides; for example, the sequence SCTFSIPPQCYG 5 was found on five independent beads. Of the positions randomized, all the active sequences found had threonine at the P 2 position; tyrosine and phenylalanine were present at P 1 ; leucine, norleucine and isoleucine were obtained at the P' 2 site. Each of the sequences was re-synthesized as soluble 11 residue peptides (the spacer was omitted), and the activity of these molecules as chymotrypsin inhibitors was measured. The inhibition constants are given in Table 1 . All the active sequences were found to display low K i values of 020 nM.
Discussion

Combinatorial libraries
Synthetic combinatorial libraries represent a significant advance in the study of molecular recognition and compound screening. They allow a large number of distinct species to be synthesized
Results
C-terminal attachment
Disulfide-linked peptide loops based on the sequence of Bowman-Birk inhibitor retain much of the inhibitory capability of the parent inhibitor protein (Nishino et al., 1977; Terada et al., 1978; Maeder et al., 1992; Domingo et al., 1995) . However, in order to screen for inhibitors using covalently linked peptides, it is first essential to demonstrate that C-terminal attachment is not detrimental to the inhibition properties. The K i value for inhibition of trypsin by the cyclic peptide SCTKSIPPQCY is 10 nM (Domingo et al., 1995) . The addition of a pentaglycine spacer resulted in an inhibitor with a K i value of 4 nM, which shows that addition of a C-terminal tail of glycine residues does not markedly change the inhibition constant. Immobilization of this latter sequence via the C terminus to a solid support was found not to prevent trypsin binding (not shown), showing that covalent attachment of this peptide loop is a viable way to screen for proteinase binding.
Synthesis of the inhibitor library
The cyclic peptide library shown in Figure 2 was synthesized by inclusion of three split-synthesis steps (Furka et al., 1991; Lam et al., 1991) . Edman sequencing of several individual resin beads was performed to verify that the correct sequence had been generated. No apparent bias was observed in these sequences, and the randomized positions showed the expected arbitrary distribution of sequences (results not shown). work, have used libraries built from peptide components . There are two conceptually distinct classes of synthetic library: those where the library components are present as a solution-phase mixture (Houghten et al., 1991; Dooley & Houghten, 1993) , and those that involve components covalently linked to a solid support (Geysen et al., 1986; Fodor et al., 1991; Lam et al., 1991) . Each has advantages and disadvantages. Solution libraries can be tested under conditions that resemble more closely a typical inhibition or binding assay, but identification of the active components can be ambiguous as such assays always involve complex mixtures. Covalently linked libraries usually allow unambiguous identification of active sequences, but screening covalently coupled compounds may be inappropriate for certain systems and it is essential that the compound retains activity when covalently attached. However, this latter problem can be overcome by a hybrid approach, where a resinbound library incorporates cleavable linkers that allow release and assay in solution (Salmon et al., 1993) .
In addition to synthetic libraries, it is possible to generate variation by genetic means. Randomized peptides can be displayed on the surface of filamentous phage (Cwirla et al., 1990; Devlin et al., 1990; Scott & Smith, 1990) . The ''phage-display'' method is a powerful means of selecting active peptide and protein sequences, and has been used to good effect in the engineering of larger protein domains, particularly antibodies (McCafferty et al., 1990; Hoogenboom et al., 1991) . The major disadvantage of phage display is its limitation to only the genetically coded amino acids. There is also some possibility of biological bias in the sequences generated by an expression system (Kay, 1994) .
Proteinase inhibition is obviously an important target for combinatorial studies, and there are several examples where libraries have been used to screen for proteinase inhibitors. Multicomponent tetrapeptide mixtures have been used to search for HIV proteinase inhibitors (Owens et al., 1991) . Solution libraries of linear peptides have been used to identify trypsin inhibitors (Eichler & Houghten, 1993) , and the same group has used solution libraries of derivatized cyclic Lys 3 Glu to screen for and tested in a short space of time. In principle, the techniques are applicable to any synthetic methodology , although most applications reported so far, including the present Table 1 . Sequences of active chymotrypsin inhibitors identified from the library
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Identified chymotrypsin inhibitors
The positions marked X in the library template represent the randomized positions corresponding to the P2, P1 and P' 2 inhibitor sites, respectively. Twenty different amino acids were introduced at each of these loci, giving a total library size of 8000 sequences. The library template was cyclized by a disulfide between the two cysteine residues, and was attached to TentaGel resin via the C-terminal residue. The Ki values were measured in solution assays using re-synthesized 11-mer peptides (the glycine spacer was omitted). chymotrypsin inhibition (Eichler et al., 1994) . Meldal & Svendsen (1995) have made use of a novel fluorogenic detection system to identify linear peptide inhibitors in a combinatorial bead library. Using phage display of BPTI variants, Roberts et al. (1992) have selected novel neutrophil elastase inhibitors.
Design of our library
For construction of the library reported here, we elected to randomize the P 2 , P 1 and P' 2 residues on the inhibitor loop. There were two concerns in this selection. First, we wished to target residues that were known to be important for interactions with the proteinase in the natural BBI-trypsin complex. This means that residues adjacent to the scissile bond become important candidates for variation. Second, it is impracticable to vary very many sites, or the library size becomes excessively large. Tsunogae et al. (1986) first described how the inhibitory loop of BBI was a two-stranded antiparallel b-sheet comprising two regions separated by the cis-Pro at P' 3 . The ''back side'' (P' 3 to P 8 ) acts principally to restrain the reactive site region in an inhibitory conformation whilst not directly interacting with the enzyme. All contacts with the proteinase are via the ''front side'' of the loop (P 3 to P' 2 ; Figure 1B ). Of these interacting residues, the P' 1 serine residue is well conserved, possibly due to its involvement in intramolecular hydrogen bonding within the inhibitor loop (Lin et al., 1993) , and the P 3 cysteine residue is essential for disulfide formation.
The multiplicity of the combinatorial bead library is limited by the size of the individual resin beads and the amount of resin that it is feasible to screen. Here, we screened approximately 32,000 beads with a theoretical 8000 different sequences present, giving an average of four copies of each sequence present in the assay. This means that the screening regime should, in principle, locate multiple copies of any active components. Various methods have been suggested that allow sequence determination from a single bead. These include direct Edman sequencing of peptide libraries (Lam et al., 1991) , use of mass spectroscopy (Brummel et al., 1994) , and indirect tagging by oligonucleotides (Brenner & Lerner, 1992; Nielsen et al., 1993) or by chromatographic markers (Ohlmeyer et al., 1993) . The sequences reported here were determined by direct Edman sequencing. Although this methodology is specific to peptide-based libraries, it is highly appropriate for the system used here and gives unambiguous results.
Sequences identified
All beads that were analyzed showed the presence of a single peptide sequence, and it is important to note that no hydrolysis product was detectable. Testing of peptide inhibitors of proteinases in solution is complicated by the inevitable presence of hydrolysis products (e.g. see Domingo et al., 1995) . However, the TentaGel resin that we have used here is essentially impermeable to proteins and only the surface of the resin bead is accessible. This means that the overwhelming majority of the peptide, which is located internally within the bead matrix, remains unaffected by the proteinase, even after extended incubation.
The screening procedure resulted in selection of 13 positive beads. Sequencing data were obtained from each of these, and all the different sequences identified were individually synthesized as 11 residue disulfide-cyclized peptides. Competitive inhibition kinetics were measured on each peptide in solution, and K i values were determined. It was found that ten of the beads (77%) had sequences that produced tight-binding chymotrypsin inhibitors, whereas three sequences did not show any competitive inhibition by the re-synthesized peptide. Non-specific binding is always a potential problem in library screening (Lam & Lebl, 1994) , and so it is essential to authenticate the activity of derived sequences. All subsequent discussion relates to the sequences that were confirmed to have inhibitory activity after assays on re-resynthesized peptides.
Implications for inhibition mechanism
The results presented in Table 1 show that a clear consensus sequence exists for chymotrypsin inhibition. It is striking that we found multiple copies for all but one of the inhibitors. This gives us confidence in the selection procedure used, as we screened sufficient resin to include, on average, four copies of each sequence. The peptide inhibitor template used in this study is expected to inhibit proteinases in the same manner as the parent BBI protein. The results of this study can therefore, by extrapolation, shed light on the structural requirements for inhibition by this class of inhibitor protein. Of the three locations varied, the P 2 site was found to contain exclusively threonine; the P 1 site had phenylalanine and tyrosine; and leucine, isoleucine and norleucine were found at P' 2 . The preference for aromatic residues at P 1 is consistent with the substrate preference of chymotrypsin (Schellenberger et al., 1991) . These results are also in accord with previous work where the P 1 residue alone was varied (Domingo et al., 1995) . The sequences obtained at the other locations were less predictable from the substrate specificity, and it is particularly striking that exclusively threonine was found at the P 2 location. In the crystal structure of mung bean inhibitor complexed to trypsin, the P 2 threonine residue is found to make internal hydrogen bonds within the inhibitor loop via the O g , and to form hydrophobic contacts via C b and C g to His57 within the catalytic triad (Lin et al., 1993) . It is likely that these interactions would be important with all serine proteinases, which explains the conservation. Nevertheless, it is surprising that we did not find any structurally homologous amino acid such as serine, which implies that the structural requirements for inhibition are quite restrictive at this site. We are currently investigating this phenomenon further by constructing a series of systematic variations at this locus. The amino acid residues identified at P' 2 are clearly related (they are isomers of each other), and suggest a preference for large aliphatic substituents at this location. Table 1 records the inhibition constants that were determined after each of the peptides identified had been individually synthesized. All the sequences were found to be potent inhibitors of chymotrypsin, with K i values of around 20 nM. To our knowledge, the K i values found for these peptides represent the lowest so far recorded for sequences based on the BBI reactive site when inhibiting chymotrypsin.
There are two features of the combinatorial library described here that distinguish it from most previous reports. First, the presence of a disulfide bond to constrain the conformation. In the context of the peptides used here, the disulfide is essential for these sequences to act as proteinase inhibitors; reduction to a linear peptide destroys the inhibitory activity. The advantages of a constrained system in this particular instance are exemplified by comparing the results of the present investigation with those obtained using libraries of linear peptides to search for trypsin inhibitors (Eichler & Houghten, 1994) . Those authors used a solution library of hexapeptides, corresponding to the reactive sites of known proteinaceous trypsin inhibitors, and a ''positional scanning'' (Dooley & Houghten, 1993) approach with lysine or arginine as the P 1 residue in fixed positions. Our constrained library, although less diverse, contained inhibitors at least three orders of magnitude more potent than those discovered for the linear peptide library. The second distinguishing feature of our system is that randomization was undertaken at a limited number of sites within a larger functional motif. This strategy has recently been applied to larger peptide domains (Bianchi et al., 1995) , and is clearly an optimal way of creating interesting functional variants when using larger systems. Indeed, the BBI loop itself can be considered to represent a small polypeptide domain, as it is a distinct structural unit that retains functional activity when isolated from the rest of the protein.
An advantage of synthetic combinatorial libraries over those produced using genetic techniques is the possibility to include residues that are not genetically encoded. Our library was quite limited in this regard, with only a single unnatural amino acid (norleucine). However, it is interesting that this amino acid was found amongst the active peptides, and it is likely that future libraries will make much more use of unnatural residues and non-peptide components.
Implications for protein design
There has been much recent interest in the use of small protein domains as scaffolds onto which novel functionality can be constructed (Pessi et al., 1993; Bianchi et al., 1995; Vita et al., 1995) . These molecules provide a means of generating conformationally defined structures, libraries of which are likely to have greater potential as pharmacophores than do simple linear sequences. The specialized scaffold used in our study is even smaller than those described above, yet still retains the constrained conformation required for functional activity.
The mechanism of action of proteinase inhibitors is well established, and changes in activity by single-site changes within the reactive site region either by natural mutation (Carrell et al., 1982) , site-directed mutagenesis (Rosenberg et al., 1984; Courtney et al., 1985; Longstaff et al., 1990) or peptide synthesis (Terada et al., 1978; Favel et al., 1989; Domingo et al., 1995) have been described. However, it seems likely that efficient tailoring of specificity between a proteinase and an inhibitor sequence would benefit from a more extensive series of changes within the inhibitor canonical loop. It is striking, and perhaps quite fortunate from a design standpoint, that very many proteinase inhibitors act by presenting a section of peptide in this particular canonical structure. This means that judicious variation of these interacting residues gives a way of engineering inhibition specificity. The work reported here is a first step in the construction of a generalized library of constrained canonical loop structures from which specific inhibitors can be selected.
Materials and Methods
Materials
N-a-9-Fluorenylmethoxycarbonyl-protected amino acids and derivatives were purchased from CalbiochemNovabiochem or Bachem with the following side-chain protecting groups: Ala, Arg(2,2,5,7,8-pentamethylchroman-6-sulfonyl), Asn(trityl), Asp(tBu), Cys(trityl), Gln(trityl), Glu(tBu), Gly, His(trityl), Ile, Leu, Lys(t-butoxycarbonyl), Met, Nle, Phe, Pro, Ser(tBu), Thr(tBu), Trp, Tyr(tBu), Val. Dimethylformamide (DMF) and N-methylpyrrolidone (NMP) were peptide synthesis grade from Rathburn Chemicals (Walkerburn, UK) and 2 -(1H -benzotriazole -1 -yl) -1,1,3,3 -tetramethyluronium hexafluorophosphate (HBTU) and N-hydroxybenzotriazole (HOBT) were from SNPE (Croydon, UK). Bovine pancreatic a-chymotrypsin (treated with Na-p-tosyl-L-lysine chloromethyl ketone), biotin N-hydoxysuccinimide ester, phenol, ethanedithiol, thioanisole, dimethylsulfoxide (DMSO), 5-bromo-4-chloro-3-indolyl phosphate (BCIP), nitro blue tetrazolium (NBT) and trifluoroacetic acid (TFA) were purchased from Sigma. Soybean trypsin inhibitor (STI; Sigma) was coupled to CNBr-activated Sepharose 4B (Pharmacia-LKB) as described by the manufacturer.
Biotin labeling of chymotrypsin a-Chymotrypsin (37 mg) was dissolved in 350 ml of 50 mM NaHCO3 (pH 9). To this was added 11 mg of biotin N-hydroxysuccinimide ester (Sigma) in 70 ml of DMF. Labeling was performed while maintaining gentle shaking for one hour. The reaction was quenched by the addition of an equal volume of 1 M ethanolamine, 1 M NaCl. Chymotrypsin was then purified by affinity chromatography using STI-Sepharose equilibrated in 50 mM Tris-HCl (pH 8), 500 mM NaCl. Active chymotrypsin was eluted with 10 mM HCl and concentrated by centrifugal ultrafiltration using a Centricon (Amicon), with a 10 kDa exclusion limit. The degree of biotinylation was determined using 4-hydroxyazobenzene-2'-carboxylic acid (Sigma) by the method of Green (1970) , and the concentration of protein was found using the BCA protein assay (Pierce) with unlabeled a-chymotrypsin as standard, to derive a biotin to protein ratio. Labeled enzyme was stored at −70°C.
Peptide synthesis and purification
Free peptides for kinetic analysis were synthesized by standard solid-phase techniques using Fmoc chemistry (Atherton & Sheppard, 1989) and HBTU/HOBT activation (Knorr et al., 1989) as described (Domingo et al., 1995) using either an Applied Biosystems (ABI) 431A peptide synthesizer at 0.1 mmol scale with fourfold excess of amino acids or a Shimadzu PSSM-8 peptide synthesizer at 0.025 mmol scale with tenfold excess of amino acids.
Cleavage of the peptides from the resin and deprotection of the side-chain protecting groups was performed using a mixture of phenol (0.75 g), ethanedithiol (0.25 ml), thioanisole (0.5 ml), water (0.5 ml) and TFA (10 ml) with stirring for two hours. Peptide was separated from resin on a sintered glass funnel, precipitated in 50 ml of ice-cold tert-methyl butyl ether (Aldrich) and collected by centrifugation at 2000 g. The precipitation was repeated five times, and the peptide was dried under vacuum over silica gel.
Disulfide bridge formation was performed using DMSO oxidation (Tam et al., 1991) . The dried peptides were dissolved in 5% (v/v) acetic acid and 20% (v/v) DMSO to give a 0.05 mg ml −1 solution. The pH was adjusted to 6 with aqueous ammonia, and stirring was performed at room temperature for 24 hours. Peptide purification was by reverse-phase HPLC using a Gilson system with a Waters C18 Radial Pak column (25 mm × 10 cm) using mobile phases of water and acetonitrile, each containing 0.1% (v/v) TFA. All peptides were characterized by FAB-MS and analytical reversephase HPLC (Waters C18 Radial Pak column 10 mm × 5 mm).
BBI library synthesis
The BBI library (Figure 2 ) was synthesized by incorporating several ''split synthesis'' steps (Furka et al., 1991; Lam et al., 1991) . Poly(ethylene glycol)-grafted polystyrene resin, TentaGel-S-NH2, was used as the solid-phase support, having a diameter of 80 mm and a substitution of 0.23 meq g −1 (Rapp Polymere, Tubingen, Germany). Five glycine residues were first attached as a spacer. Next, the C-terminal portion of the 11 residue peptide, up to and including the proline P' 3 residue was synthesized on the ABI 431A synthesizer as described earlier, but using the 0.25 mmol scale. The N terminus was deprotected before equal separation into 20 capped polypropylene tubes in order to carry out the split synthesis. These contained individually 0.125 mmol in DMF of all the natural L-amino acids (except for cysteine) and L-norleucine as their pentafluorophenyl (OPfp) esters or 3-hydroxy-4-oxo-3,4-dihydro-1,2,3-benzotriazine(Odhbt) (serine and threonine) esters. One equivalent of HOBT to amino acid was included as catalyst and the final volume was 2.5 ml in DMF. Coupling was allowed to proceed for two hours with shaking. Reagent was removed by filtration and the resin was washed with NMP. The individual tubes were then re-pooled into the reaction vessel of the ABI 431A synthesizer and N-terminal deprotection conducted on the synthesizer as described above. The next residue, serine at the P' 1 position, was added on the synthesizer. The split synthesis procedure was then repeated for the P1 and P2 residues. The remaining two residues were added, and final Fmoc deprotection performed, on the synthesizer. The resin-bound library was washed with methanol and dried. Deprotection was performed as above using 15 ml of the cleavage mixture for 3.5 hours at room temperature with gentle shaking. The library was washed on a sintered glass filter with TFA followed by methanol and again dried overnight. Cyclization was performed as described previously using a one liter solution of 5% acetic acid, 20% DMSO pH 6 with gentle shaking for 48 hours. Control experiments established that these conditions allow intramolecular disulfide formation to occur in almost quantitative yield (McBride et al., 1996) . The resin was then finally filtered, thoroughly washed with water and methanol, dried and stored at 4°C.
Screening the BBI library for chymotrypsin inhibitors
The library was washed with PBS-T, and sufficient was resuspended in this buffer to give approximately 32,000 beads in a volume of 6.5 ml. Biotin chymotrypsin was added to give a final concentration of 0.36 mM, and the suspension incubated for 15 minutes at room temperature on a shaker. The beads were then thoroughly washed with PBS-T and collected on a Millipore RA 1.2 mm filter. They were then resuspended in 10 ml of PBS-T containing 25 mg ml −1 Extravidin-alkaline phosphatase (Sigma Chemical Co.; Extravidin is a chemically modified form of Avidin) in PBS-T for one hour at room temperature with gentle shaking. Again the beads were thoroughly washed with PBS-T followed by 100 mM Tris-HCl (pH 9.5), 0.5 mM MgCl2. The beads were re-suspended in 10 ml of the same buffer with 35 mM BCIP, 37 mM NBT as alkaline phosphatase substrate for approximately five minutes. The reaction was then quenched by immediate re-filtration and washing with 25 mM EDTA (pH 7.4). Positively stained beads were detected by visualization under a low-power microscope and transferred individually to glass-fiber sequencing filters. The filters with their single beads were washed with 50 mM HCl, air-dried and then the bead sequenced by standard Edman degradation on an ABI 467A protein sequencer.
Kinetic measurements
Enzymatic hydrolysis of N-succinyl-Ala-Ala-Pro-Phe p-nitroanilide (Sigma) was conducted at 25°C in 144 mM . Absorbance increase at 410 nm was measured upon addition of chymotrypsin. The substrate concentration was determined from the final absorbance (e = 8800, Erlanger et al., 1961) . For Km and kcat determination of labeled and unlabeled chymotrypsin, a range of substrate concentrations were examined. The initial slopes were converted into molar rates and the kinetic constants obtained by non-linear regression (Leatherbarrow, 1990 ) using the GraFit computer program (Leatherbarrow, 1992) .
Inhibition kinetics
The inhibition kinetics were measured for various active peptides identified from the biotin-chymotrypsin screening. These were determined by competitive binding studies using the chromogenic substrate succinyl-Ala-Ala-Pro-Phe-p-nitroanilide. Assays were performed at pH 7.8 in 144 mM Tris-HCl. The active chymotrypsin concentration was measured by active site titration with p-nitrophenyl acetate (Bender et al., 1966) and peptide concentrations by the absorbance at 280 nm (Edelhoch, 1967) . Substrate hydrolysis was monitored at 410 nm and substrate concentration determined by the final absorbance at 410 nm. Initial velocity data were fit using the GraFit software package to find Ki. Values of Ki were corrected to account for competition by substrate (Ki = Ki(observed)/(1 + [S]/Km)).
